55 related articles for article (PubMed ID: 2503655)
21. He is happy whom the Muses love. Micronase (sulfonylurea) overdose.
Mack RB
N C Med J; 1989 Jun; 50(6):312-4. PubMed ID: 2500605
[No Abstract] [Full Text] [Related]
22. The sulfonylurea controversy: much ado about nothing or cause for concern?
Brady PA; Jovanovic A
J Am Coll Cardiol; 2003 Sep; 42(6):1022-5. PubMed ID: 13678924
[No Abstract] [Full Text] [Related]
23. Do ATP-sensitive potassium channels play a role in myocardial stunning?
Gross GJ
Basic Res Cardiol; 1995; 90(4):266-8. PubMed ID: 8534242
[No Abstract] [Full Text] [Related]
24. Potassium channels: basic aspects, functional roles, and medical significance.
Yost CS
Anesthesiology; 1999 Apr; 90(4):1186-203. PubMed ID: 10201693
[No Abstract] [Full Text] [Related]
25. [Inappropriate use of sulfonylureas in older adults].
Pacheco J
Rev Med Chil; 2016 Nov; 144(11):1497. PubMed ID: 28394970
[No Abstract] [Full Text] [Related]
26. [Reply. Inappropriate use of sulfonylureas in older adults].
Passi Á
Rev Med Chil; 2016 Nov; 144(11):1497-1498. PubMed ID: 28394971
[No Abstract] [Full Text] [Related]
27. Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K
Yasar U; Babaoglu MO
Acta Pharmacol Sin; 2019 Apr; 40(4):569-570. PubMed ID: 30254364
[No Abstract] [Full Text] [Related]
28. Interactive regulation of the ATP-sensitive potassium channel of cardiac muscle.
Findlay I
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S6-11. PubMed ID: 7898107
[TBL] [Abstract][Full Text] [Related]
29. ATP-sensitive potassium channels, transmural ischemia and the ECG implications for the non-insulin dependent diabetic patient?
Wilde AA
Cardiovasc Res; 1996 May; 31(5):688-90. PubMed ID: 8763397
[No Abstract] [Full Text] [Related]
30. [ATP-sensitive potassium channels and substances affecting them].
Pospísilová Y
Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
[TBL] [Abstract][Full Text] [Related]
31. Sulphonylureas, magnesium and cardiac K+ ATP channels.
Matz R
Diabetologia; 2000 Aug; 43(8):1080-1. PubMed ID: 10990091
[No Abstract] [Full Text] [Related]
32. ATP-sensitive K+ channels and insulin secretion: their role in health and disease.
Ashcroft FM; Gribble FM
Diabetologia; 1999 Aug; 42(8):903-19. PubMed ID: 10491749
[No Abstract] [Full Text] [Related]
33. [Pharmacodynamics of second-generation sulfonylureas: dose-effect curve of gliquidone in type II diabetics].
Procacci V; Giovine A; Roberto MG; Ronchi AM; Lasorsa G; Vendemiale G; Stufano N; Altomare E
Boll Soc Ital Biol Sper; 1988 Aug; 64(8):731-8. PubMed ID: 3214573
[No Abstract] [Full Text] [Related]
34. [Identification, function mechanisms and regulation of potassium channels sensitive to ATP which are targets of sulfonylureas used in the treatment of type II diabetes mellitus].
Fosset M; De Weille J; Schmid-Antomarchi H; Bernardi H; Lazdunski M
Journ Annu Diabetol Hotel Dieu; 1989; ():7-11. PubMed ID: 2503655
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]